comprehensive -WSS

comprehensive

author：fashion 2025-10-02 11:08:19 - browse：1122

Gilead office remdesivir — Yichuan Cao/Sipa USA

Gilead Sciences said Monday it will acquire CymaBay Therapeutics for $4.3 billion, adding a new treatment for a liver disease that is on track for approval later this year.

The deal values CymaBay at $32.50 per share, 27% higher than the stock’s close last Friday. That’s a relatively small takeout premium, but CymaBay shares have doubled in value since last fall on growing investor confidence in the company’s lead drug and speculation that the company could be acquired.

CymaBay’s drug, called seladelpar, is being developed for the treatment of primary biliary cholangitis, or PBC, a type of liver disease mainly affecting women that causes decreased liver function, and debilitating itching and fatigue. Progression of PBC to more advanced stages increases the risk of liver-related death.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Experimental asthma app from Apple and Anthem shows promise

focus

WSS

In new study, freeze

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Experimental asthma app from Apple and Anthem shows promise

Russian special forces kill a gunman who broke into a private house near Moscow

Russian special forces kill a gunman who broke into a private house near Moscow

focus

comprehensive

leisure time

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

NIH chief: government has fallen behind pharma on clinical trials

Peter Hotez and the public health issue of online harassment

UnitedHealth sued over use of algorithm in Medicare Advantage plans

United colonoscopy coverage change 'may cost lives,' doctors say

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Activists slam private health insurers over coverage restrictions

What is STAT's opinion section for?

Novavax promises a turnaround & Lilly roils the obesity market

Publishing genetic code of viruses could cause disaster

focus

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Healthy food access boosts outcomes in two studies

How state and local governments are sidelining science

Will.i.am, Britney Spears release new single, 'Mind Your Business'

What is STAT's opinion section for?

HIPAA doesn't protect reproductive records from prosecutors

focus

Wikipedia

entertainment

explore